Skip to content
GLP-1 Decoder

Liraglutide for Type 2 Diabetes: Evidence, Eligibility

Liraglutide is FDA approved for type 2 diabetes as Victoza. In SCALE Obesity and Prediabetes, people on Saxenda lost 7.4% of body weight on average, vs 3% on placebo.

Brands
Victoza and Saxenda
Best result (SCALE Obesity and Prediabetes)
7.4% weight loss

Saxenda: a quick look

Time it stays inside the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours: after 13 h half is gone, and after five half-lives (2.7 d) about 3% is left.

How much weight came off in the main trial
Saxenda (SCALE Obesity and Prediabetes)7.4%Placebo3%

In SCALE Obesity and Prediabetes, 56 weeks, the result was 7.4% of body weight versus 3% on placebo.

Source for warnings: FDA label (DailyMed).

Who qualifies?

Who qualifies for liraglutide
MedicineWho qualifies
VictozaUsed with diet and exercise, it lowers blood sugar for adults and children 10 and older who have type 2 diabetes.
VictozaFor adults with heart disease and type 2 diabetes, it lowers the chance of a heart attack, stroke, or death related to the heart.
SaxendaChildren or adults aged 12 and older (over 60 kg) with obesity can use it to lose weight with diet and activity and keep the weight off over time. It also applies to adults who are overweight and also have a weight-related condition.

Sources: the FDA label on DailyMed 1 2.

Results from type 2 diabetes trials

Liraglutide studies in type 2 diabetes
TrialMedicineWho took partLengthPeopleMain resultComparison
SCALE Obesity and Prediabetes SaxendaAdults with obesity, or adults who are overweight, as long as they do not have type 2 diabetes56 weeks3,7317.4% weight loss3% on placebo

Study cited: SCALE Obesity and Prediabetes (FDA label (DailyMed)).

What is different for type 2 diabetes?

Points on type 2 diabetes from the liraglutide label
What changesWhat the label saysLabels
HypoglycemiaWhen you take it with insulin or a sulfonylurea, low blood sugar becomes more likely, and lowering those doses may be needed.All of them
Taken with insulin or sulfonylureasIf you use this medicine alongside insulin or a sulfonylurea, including glipizide or glimepiride, you are more likely to have low blood sugar. The doctor may reduce the amount of each you take.All of them

The source is FDA labels: FDA label (DailyMed).

From the label warnings: FDA DailyMed label.

Coverage for type 2 diabetes

Medicare Part D may cover these medicines when they are prescribed for diabetes or cardiovascular disease.

Sources: humana.com.

Alternatives for type 2 diabetes

GLP-1 medicines and type 2 diabetes
MedicineFor type 2 diabetesHow it is takenTrial result
VictozaFDA approveddaily injectionNot listed
OzempicFDA approvedweekly injectionNot listed
RybelsusFDA approveddaily tabletNot listed
MounjaroFDA approvedweekly injectionA1C down 2.3 points
TrulicityFDA approvedweekly injectionA1C down 1.77 points
ByettaFDA approvedtwice-daily injectionNot listed
SaxendaNot an approved usedaily injection7.4% weight loss
WegovyNot an approved useweekly injection or daily tablet9.6% weight loss
ZepboundNot an approved useweekly injection14.7% weight loss
FoundayoNot an approved usedaily tablet9.6% weight loss

Sources: FDA label (DailyMed), PubMed.

Questions to ask your prescriber